Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Transitioning Survival from Months to Years in Advanced NSCLC
Author
Howard (Jack) West, MD

This is a slide presentation I did last week at a local conference, describing the steady, incremental improvements in survival with advanced/metastatic non-small cell lung cancer (NSCLC) that have occurred over the past 10-15 years.  There are still many pessimists who highlight that we haven't cured metastatic lung cancer or most other advanced cancers, but I would contend that it is quite meaningful to be able to tell a patient with cancer that your treatment is quite likely to improve their survival and that, because of it, an ever-growing proportion of patients are living years with it, rather than the expectation of months that prevailed several years ago. 

This presentation highlights a couple of key developments:

1) More patients are receiving more lines of effective therapy. For patients with responsive cancer (unfortunately not everyone with advanced NSCLC), survival is improved not just with first line but also with later lines of treatment. Approaches like maintenance therapy and routine use of second line and later therapy translates to far more patients living beyond a year, sometimes well into the range of years, even independent of molecular markers.

2) A growing minority of patients are found to have a cancer that appears "driven" by a key biomarker for which we have a proven or potential target. Starting with EGFR mutations, seen in about 10% of NSCLC patients in North America, and then ALK rearrangements in another 4-5%, we've since added ROS1 and are looking at additional potentially fruitful targets like BRAF, HER2, and others.  These responses tend to be dramatic and prolonged. Even if the responses lasting years are only available to a minority of patients, we are adding to that minority year after year.

Of note, this slide deck does NOT cover immunotherapy. In part, this is because these strategies still have undefined, unproven benefit.  In addition, immunotherapy for lung cancer was the subject of a separate talk, and I did not want to encroach on that topic.

Here's the presentation. I hope you find it thought-provoking and encouraged that we're making progress, even if it can never be fast enough.

 

Next Previous link

Previous PostNext Post

Related Content

Image
Clinical Trials Storytelling 2025
Article
GRACE is pleased to introduce three amazing individuals participating in the 2024-25 GRACE Clinical Trials Experiences Storytelling Program
Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated. 
Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!

Forum Discussions

Can SCLC also be treated with targeted therapy?

Hi amitchouhan,

Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...

I was searching for this, Thank you so much for the info.

Glad to help.  FYI, I just edited the link, which has the agenda and links to oncologists' bios. Plus, the link is also on our home page, https://cancergrace.org/

Hope to see...

Recent Comments

JOIN THE CONVERSATION
Glad to help.  FYI, I just…
By JanineT GRACE … on
I was searching for this,…
By LilahStapleton on
Hi and welcome.  I'm sorry…
By JanineT GRACE … on
Hi amitchouhan,

Welcome to…
By JanineT GRACE … on